Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

NCT02584309 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02584309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02584309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Inferiority Study of Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
February 22, 2016
Completion date
July 17, 2022
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angiosarcoma, epithelioid sarcoma, fibrosarcoma, leiomyosarcoma, liposarcoma, malignant peripheral nerve sheath tumor, myxofibrosarcoma, sarcoma, soft tissue, soft tissue sarcoma, synovial sarcoma, undifferentiated pleomorphic sarcoma